Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 23, 2023 15:17 ET | Source: Robbins LLP

BTAI Investors Should Contact Robbins LLP About Participating in the Class Action Against BioXcel Therapeutics

SAN DIEGO, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel...
July 26, 2023 07:46 ET | Source: Robbins LLP

BioXcel Therapeutics, Inc. Investors: Contact Robbins LLP if You Incurred Significant Losses in BTAI

NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel...
July 20, 2023 14:53 ET | Source: Robbins LLP

BioXcel Therapeutics, Inc. (BTAI) Sued by Shareholders: BTAI Investors Should Contact Robbins LLP for Information About Their Rights

SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel...
July 13, 2023 17:57 ET | Source: Robbins LLP

BioXcel Therapeutics, Inc. (BTAI) Investor Alert: Robbins LLP Reminds Investors of Class Action Against BioXcel Therapeutics, Inc.

SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired BioXcel...